Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".
Department of Gyn/OB, University of Tübingen, Calwer Str 7, 72076 Tübingen, Germany. tanja.fehm@med.uni-tuebingen.de
T
T
Fehm
W
W
Sauerbrei
D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000097:blood / Q000401:mortality* / Q000473:pathology; D002452:Cell Count; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008954:Models, Biological; D015337:Multicenter Studies as Topic; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D011446:Prospective Studies; D012107:Research Design
D014408:Biomarkers, Tumor